Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders

NCT01302964 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorders

Interventions

DRUG: Placebo
DRUG: Mirtazapine

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]